Peptides at the Edge: How to Operate Where Cosmetics, Wellness, and Therapeutics Collide, HBW Insight

Partner Rachel Raphael co-authored an article for HBW Insight examining the legal and regulatory challenges surrounding peptide-based beauty and wellness products, which increasingly blur the lines between cosmetics, wellness products, and regulated therapeutics.

The article explores how peptide innovation is testing regulatory frameworks that rely on intended use and substantiated claims to distinguish cosmetics from drugs. Rachel and her co-author discuss how mechanistic and science-based marketing claims can create regulatory risk, particularly when products are positioned as affecting biological processes associated with repair, regeneration, or longevity.

Read the full HBW Insight article >>
Subscription may be required.